期刊文献+

PIK3CA、CCL5、Survivin基因与甲状腺癌相关性的新发现 被引量:1

Relationship Between PIK3CA,CCL5 and Survivin Gene and Thyroid Cancer
下载PDF
导出
摘要 三种基因PIK3CA、CCL5、Survivin参与多种疾病过程,尤其与癌症关系密切。研究表明,PIK3CA、CCL5、Survivin基因多态性在甲状腺癌的发生、浸润、转移、治疗和预后方面发挥重要作用。 PIK3CA, CCL5 and Survivin gene were involved in the processes of many diseases and especially played an important role in cancers. Recent researches showed that PIK3CA, CCL5 and Survivin gene polymorphism have an obvious impact on the tumorigenesis, invasion, metastasis, therapy and prognosis of thyroid cancer.
作者 庄天微 乔虹
出处 《标记免疫分析与临床》 CAS 2014年第1期12-14,共3页 Labeled Immunoassays and Clinical Medicine
基金 黑龙江省自然科学基金项目(ZD201220) 哈尔滨市创新人才项目(2008RFQXS092) 哈尔滨医科大学附属二院博士启动基金(BS2008-06)
关键词 CCL5 基因多态性 甲状腺癌 PIK3CA CCL5 Survivin Gene polymorphism Thyroid cancer
  • 相关文献

参考文献14

  • 1苏娇,贺小峰,王苏兰.PIK3CA基因的生物信息学分析[J].长治医学院学报,2010,24(2):91-94. 被引量:4
  • 2Xing J C,Tufano R P, Murugan A K, et al. Single nucleotide polymorphism rs17849071G/T in the PIK3CA gene is inversely associated with follicular thyroid cancer and PIK3CA amplification. PLoS One,2012,7(11).
  • 3Hirsch E Lembo G, Montrucchio G, et al. Signaling through Pi3Kgamma: a common platform for leukocyte, platelet and cardiovascular stress sensing. Thromb Haemost, 2006, 95 ( 1 ) :29- 35.
  • 4Cantley L C. The phosphoinositide 3-kinase pathway. Science, 2002,296 ( 5573 ) : 1655-1657.
  • 5杨扬,高月秋.PIK3CA突变在人类癌症发生中的作用[J].国际遗传学杂志,2008,31(2):111-114. 被引量:4
  • 6Teicher B A, Fficker P. CXCLI2 ( SDF-I )/CXCR4 pathway in cancer. Clin Cancer Res,2010,16( 11 ) :2927-2931.
  • 7Kwon K H,Lee Y C, Chung J H, et al. Association study of chemokine (C-C motif) ligand 5 gene polymorphism and papillal.'y thyroid cancer. J lnvest Surg,2013,26 ( 6 ) : 319- 324.
  • 8吴凤,涂亚庭,陈思远.趋化因子及其受体在肿瘤生长中的作用及抗肿瘤治疗的展望[J].实用医院临床杂志,2013,10(1):18-21. 被引量:5
  • 9Weng C J,Chien M H, Lin C W, et al. Effect of CC chemokine ligand 5 and CC chemokine receptor 5 genes polymorphisms on the risk and clinicopathological development of oral cancer. Oral Oncol, 2010,46:767-772.
  • 10Azenshtein E,Luboshits G, Shina S, et al. The CC chemnkine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity. Cancer Res, 2002,62 : 1093-1102.

二级参考文献117

共引文献33

同被引文献19

  • 1Weitz J,Koch M,Debus J,et al.Colorectal cancer[J].Lancet,2005,365(9454):1066-1066.
  • 2Yang Y,Gu X,Zhou M,et al.Serum micro RNAs:A new diagnostic method for colorectal cancer[J].Biomedical Reports,2013,1(4):495-498.
  • 3Ryunosuke K,Koshi M,Fumiaki T,et al.Clinical significance of mi R-146a in gastric cancer cases[J].Clinical Cancer Research An Official Journal of the American Association for Cancer Research,2011,17(13):4277-4284.
  • 4Bond G L,Hu W,Bond E E,et al.A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans[J].Cell,2004,119(5):591-602.
  • 5Gellad Z F,Provenzale D.Colorectal cancer:national and international perspective on the burden of disease and public health impact[J].Revista Brasileira De Farmacognosia,2010,138(6):2177-2190.
  • 6张润虎,张树春,白涛.包头地区结直肠癌发病风险因素的病例对照研究[J].世界最新医学信息文摘(连续型电子期刊),2014,13(36):11-12.
  • 7Anastasia K,Angela R,Jayasena S D.Functional si RNAs and mi RNAs exhibit strand bias[J].Cell,2003,115(2):209-216.
  • 8Ryan B M,Robles A I,Harris C C.Genetic variation in micro RNA networks:the implications for cancer research[J].Nature Reviews Cancer,2010,10(6):389-402.
  • 9Sloane M A,Wong J W H,Dilmi P,et al.Epigenetic inactivation of the candidate tumor suppressor USP44 is a frequent and early event in colorectal neoplasia[J].Epigenetics Official Journal of the Dna Methylation Society,2014,9(8):1092-1100.
  • 10Azimzadeh P,Romani S,Mirtalebi H,et al.Association of costimulatory human B-lymphocyte antigen B7-2(CD86)gene polymorphism with colorectal cancer risk[J].Gastroenterology&Hepatology from Bed to Bench,2013,6(2):86-91.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部